Akbar S. Khan
Edgewood Chemical Biological Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Akbar S. Khan.
Applied and Environmental Microbiology | 2006
Kevin P. O'Connell; Jennifer R. Bucher; Patricia E. Anderson; Cheng J. Cao; Akbar S. Khan; Mark V. Gostomski; James J. Valdes
ABSTRACT Bacteriophage MS2 is used in place of pathogenic viruses in a wide variety of studies that range from testing of compounds for disinfecting surfaces to studying environmental transport and fate of pathogenic viruses in groundwater. MS2 is also used as a pathogen simulant in the research, development, and testing (including open air tests) of methods, systems, and devices for the detection of pathogens in both the battlefield and homeland defense settings. PCR is often used as either an integral part of such detection systems or as a reference method to assess the sensitivity and specificity of microbial detection. To facilitate the detection of MS2 by PCR, we describe here a set of real-time fluorogenic reverse transcription-PCR assays. The sensitivity of the assays (performed with primer pairs and corresponding dye-labeled probes) ranged from 0.4 to 40 fg of MS2 genomic RNA (200 to 20,000 genome equivalents). We also demonstrate the usefulness of the primer pairs in assays without dye-labeled probe that included the DNA-binding dye SYBR green. None of the assays gave false-positive results when tested against 400 pg of several non-MS2 nucleic acid targets.
Applied and Environmental Microbiology | 2006
Vito G. DelVecchio; Joseph P. Connolly; Timothy G. Alefantis; Alexander Walz; Marian A. Quan; Guy Patra; John M. Ashton; Jessica Whittington; Ryan Chafin; Xudong Liang; Paul Grewal; Akbar S. Khan; Cesar V. Mujer
ABSTRACT Differentially expressed and immunogenic spore proteins of the Bacillus cereus group of bacteria, which includes Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis, were identified. Comparative proteomic profiling of their spore proteins distinguished the three species from each other as well as the virulent from the avirulent strains. A total of 458 proteins encoded by 232 open reading frames were identified by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry analysis for all the species. A number of highly expressed proteins, including elongation factor Tu (EF-Tu), elongation factor G, 60-kDa chaperonin, enolase, pyruvate dehydrogenase complex, and others exist as charge variants on two-dimensional gels. These charge variants have similar masses but different isoelectric points. The majority of identified proteins have cellular roles associated with energy production, carbohydrate transport and metabolism, amino acid transport and metabolism, posttranslational modifications, and translation. Novel vaccine candidate proteins were identified using B. anthracis polyclonal antisera from humans postinfected with cutaneous anthrax. Fifteen immunoreactive proteins were identified in B. anthracis spores, whereas 7, 14, and 7 immunoreactive proteins were identified for B. cereus and in the virulent and avirulent strains of B. thuringiensis spores, respectively. Some of the immunodominant antigens include charge variants of EF-Tu, glyceraldehyde-3-phosphate dehydrogenase, dihydrolipoamide acetyltransferase, Δ-1-pyrroline-5-carboxylate dehydrogenase, and a dihydrolipoamide dehydrogenase. Alanine racemase and neutral protease were uniquely immunogenic to B. anthracis. Comparative analysis of the spore immunome will be of significance for further nucleic acid- and immuno-based detection systems as well as next-generation vaccine development.
Journal of Chemical Information and Modeling | 2006
Akbar S. Khan; Cesar V. Mujer; Timothy G. Alefantis; Joseph P. Connolly; Ulrike Beate Mayr; Petra Walcher; Werner Lubitz; Vito G. DelVecchio
The potential devastation resulting from an intentional outbreak caused by biological warfare agents such as Brucella abortus and Bacillus anthracis underscores the need for next generation vaccines. Proteomics, genomics, and systems biology approaches coupled with the bacterial ghost (BG) vaccine delivery strategy offer an ideal approach for developing safer, cost-effective, and efficacious vaccines for human use in a relatively rapid time frame. Critical to any subunit vaccine development strategy is the identification of a pathogens proteins with the greatest potential of eliciting a protective immune response. These proteins are collectively referred to as the pathogens immunome. Proteomics provides high-resolution identification of these immunogenic proteins using standard proteomic technologies, Western blots probed with antisera from infected patients, and the pathogens sequenced and annotated genome. Selected immunoreactive proteins can be then cloned and expressed in nonpathogenic Gram-negative bacteria. Subsequently, a temperature shift or chemical induction process is initiated to induce expression of the PhiX174 E-lysis gene, whose protein product forms an E tunnel between the inner and outer membrane of the bacteria, expelling all intracellular contents. The BG vaccine system is a proven strategy developed for many different pathogens and tested in a complete array of animal models. The BG vaccine system also has great potential for producing multiagent vaccines for protection to multiple species in a single formulation.
Molecular and Cellular Probes | 2003
Akbar S. Khan; Cheng J. Cao; Roy G. Thompson; James J. Valdes
The bioterrorism threat is perceived to be a real challenge to our nations security. This threat has necessitated the design of better and faster assays for the detection of biothreat agents including staphylococcal enterotoxin B (SEB), a causative agent of food poisoning. This study describes a simple, fast and highly sensitive fluorescence-based immunoassay, in which the antibody is fluorescently-labeled for use in this assay. Use of labeled antibodies resulted in very low level of detection of SEB, 100 pg/well. This method is four times faster than classical and conventional enzyme-linked immunosorbent assay (ELISA).
Molecular and Cellular Probes | 2004
Tim Alefantis; Paul Grewal; John M. Ashton; Akbar S. Khan; James J. Valdes; Vito G. Del Vecchio
Biotechnology Letters | 2003
Akbar S. Khan; Roy G. Thompson; Cheng Cao; James J. Valdes
Archive | 2007
Kevin P. O'Connell; Akbar S. Khan; Cheng J. Cao; Jennifer R. Bucher; Mark V. Gostomski; James J. Valdes; Patricia E. Anderson
Archive | 2010
Cheng J. Cao; Akbar S. Khan; Kevin P. O'Connell; Jennifer R. Bucher; Mark V. Gostomski; James J. Valdes
Archive | 2003
Akbar S. Khan; Jennifer W. Sekowski; Maha Khalil; Martin Nau; Kevin O’Connell; Maryanne Vahey; James J. Valdes; Mohyee E. Eldefrawi
Archive | 2002
Kevin P. O'Connell; Akbar S. Khan; Patricia E. Anderson; James J. Valdes; Sarah Cork